Announcements Trials
Browse Landscape

Status

Recruiting 758Active not recruiting 289Not yet recruiting 124Completed 94Terminated 31Withdrawn 9Enrolling by invitation 9Available 8Suspended 5No longer available 2

Sponsor Class

INDUSTRY 2

Study Type

Expanded_access 2

Sponsor

Cancer Type

Genitourinary 1CNS 1

Conditions

Glioma 1Carcinoma, Renal Cell 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
No longer available × INDUSTRY × 30 days × Clear all
NCT06090331 2026-05-29

89Zr-DFO-girentuximab Expanded Access Program (EAP)

Telix Pharmaceuticals (Innovations) Pty Limited

No longer available
Genitourinary

Carcinoma, Renal Cell

NCT06743100 2026-05-29

18F-Floretyrosine Expanded Access Program

Telix Pharmaceuticals (Innovations) Pty Limited

No longer available
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡